KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Resmed (RMD) Shares Issued (2016 - 2025)

Historic Shares Issued for Resmed (RMD) over the last 17 years, with Q4 2025 value amounting to $29.6 million.

  • Resmed's Shares Issued rose 997.14% to $29.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $76.9 million, marking a year-over-year increase of 1340.37%. This contributed to the annual value of $74.4 million for FY2025, which is 4020.23% up from last year.
  • Resmed's Shares Issued amounted to $29.6 million in Q4 2025, which was up 997.14% from $8.2 million recorded in Q3 2025.
  • Resmed's Shares Issued's 5-year high stood at $30.2 million during Q2 2025, with a 5-year trough of $145000.0 in Q1 2021.
  • In the last 5 years, Resmed's Shares Issued had a median value of $14.0 million in 2021 and averaged $14.0 million.
  • Its Shares Issued has fluctuated over the past 5 years, first crashed by 9201.1% in 2021, then soared by 184068.97% in 2022.
  • Quarter analysis of 5 years shows Resmed's Shares Issued stood at $19.1 million in 2021, then increased by 15.47% to $22.1 million in 2022, then fell by 11.48% to $19.5 million in 2023, then surged by 37.66% to $26.9 million in 2024, then rose by 9.97% to $29.6 million in 2025.
  • Its Shares Issued stands at $29.6 million for Q4 2025, versus $8.2 million for Q3 2025 and $30.2 million for Q2 2025.